Volgen
Eric Sirota
Eric Sirota
Onbekend partnerschap
Geverifieerd e-mailadres voor merck.com
Titel
Geciteerd door
Geciteerd door
Jaar
Perspectives on the current state, challenges, and opportunities in pharmaceutical crystallization process development
A Cote, D Erdemir, KP Girard, DA Green, MA Lovette, E Sirota, NK Nere
Crystal Growth & Design 20 (12), 7568-7581, 2020
662020
Process development and control with recent new FBRM, PVM, and IR
G Zhou, A Moment, J Cuff, W Schafer, C Orella, E Sirota, X Gong, C Welch
Organic Process Research & Development 19 (1), 227-235, 2015
292015
Manufacturing process development for belzutifan, part 5: a streamlined fluorination–dynamic kinetic resolution process
T Wang, EM Phillips, SM Dalby, E Sirota, S Axnanda, CS Shultz, P Patel, ...
Organic Process Research & Development 26 (3), 543-550, 2021
272021
Development of a Robust Manufacturing Route for Molnupiravir, an Antiviral for the Treatment of COVID-19
PS Fier, Y Xu, M Poirier, G Brito, M Zheng, R Bade, E Sirota, K Stone, ...
Organic process research & development 25 (12), 2806-2815, 2021
192021
Development of a commercial manufacturing route to 2-fluoroadenine, the key unnatural nucleobase of islatravir
CM Hong, Y Xu, JYL Chung, DM Schultz, M Weisel, RJ Varsolona, ...
Organic Process Research & Development 25 (3), 395-404, 2020
172020
Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264) Part 2: Development of a Robust Process for Phenol Synthesis
F Peng, GR Humphrey, KM Maloney, D Lehnherr, M Weisel, F Lévesque, ...
Organic Process Research & Development 24 (11), 2453-2461, 2020
152020
Effective control of crystal size via an integrated crystallization, wet milling, and annealing recirculation system
W Meng, E Sirota, H Feng, JP McMullen, L Codan, AS Cote
Organic Process Research & Development 24 (11), 2639-2650, 2020
142020
New reactions and processes for the efficient synthesis of a HCV NS5b prodrug
RK Orr, JMMC Dunn, A Nolting, AM Hyde, ER Ashley, J Leone, E Sirota, ...
Green chemistry 20 (11), 2519-2525, 2018
142018
Determining particle‐size distributions from chord length measurements for different particle morphologies
J Schoell, R Irizarry, E Sirota, C Mengel, L Codan, A Cote
AIChE Journal 65 (5), e16560, 2019
122019
Prevalence of impurity retention mechanisms in pharmaceutical crystallizations
FL Nordstrom, E Sirota, C Hartmanshenn, TT Kwok, M Paolello, H Li, ...
Organic Process Research & Development 27 (4), 723-741, 2023
112023
Crystallization process development for the final step of the biocatalytic synthesis of Islatravir: Comprehensive crystal engineering for a low-dose drug
E Sirota, T Kwok, RJ Varsolona, A Whittaker, T Andreani, S Quirie, ...
Organic Process Research & Development 25 (2), 308-317, 2021
102021
Improving the filterability of particles by healing the seed particles
L Codan, E Sirota, A Cote
Organic Process Research & Development 22 (9), 1131-1142, 2018
102018
Cross-pharma collaboration for the development of a simulation tool for the model-based digital design of pharmaceutical crystallization processes (CrySiV)
B Szilagyi, WL Wu, A Eren, J Mackey, S Kshirsagar, E Szilagyi, ...
Crystal Growth & Design 21 (11), 6448-6464, 2021
92021
CRYSTALLIZATION: the pursuit of a robust approach for growing crystals directly to target size
A Cote, E Sirota
American Pharmaceutical Review 13 (7), 46, 2010
82010
Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264). Part 6: Development of an Improved Commercial Salt Formation Process
KM Maloney, SW Zhang, AE Mohan, AY Lee, P Larpent, H Ren, ...
Organic process research & development 24 (11), 2498-2504, 2020
62020
Preparation of crystalline forms of dihydropyrazolopyrimidinone
R Petrova, E Sirota, R Wenslow
US Patent 8,703,779, 2014
62014
Leveraging Synergistic Solubility in the Development of a Direct Isolation Process for Nemtabrutinib
Y Chen, L Iuzzolino, SA Burgess, CK Chung, J Corry, M Crawford, ...
Organic Process Research & Development 27 (4), 659-668, 2023
42023
Development of an Efficient Route to 2-Ethynylglycerol for the Synthesis of Islatravir
SM Rummelt, J Qi, Y Chen, JF Dropinski, G Hughes, JT Kuethe, D Li, ...
22021
Manufacturing Process Development for the Biaryl Ether Fragment of Nemtabrutinib (MK-1026)
NR Deprez, HB Rose, BK Peters, A Diaz-Santana, Z Liu, N Kuhl, ...
Organic Process Research & Development 27 (11), 1965-1974, 2023
12023
Method to rapidly identify potential solvent systems for crystallization of cocrystals
L Codan, L Daza, E Sirota
Organic Process Research & Development 27 (3), 513-522, 2023
12023
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20